Healthcare >> CEO Interviews >> October 14, 2002
DR. TAKASHI KIYOIZUMI is co-Founder, President, CEO and a Board member
of MediciNova, Inc. As President and CEO, Dr. Kiyoizumi is responsible
for ensuring that MediciNova adheres to its corporate mission of
marrying business discipline with scientific expertise to develop and
commercialize therapeutic agents with significant market potential. He
has over 20 years of experience in corporate management and clinical
medicine both in the US and Japan, including positions at ImmuLogic
Pharmaceutical Corporation and Interneuron Pharmaceuticals, Inc., where
he was most recently the Senior Vice President of Business Development
and Strategic Planning. Prior to his tenure in the biopharmaceutical
industry, Dr. Kiyoizumi was an academic physician and a board-certified
plastic and reconstructive surgeon. In addition, Dr. Kiyoizumi was
formerly President and Chief Executive Officer of Tanabe Research
Laboratories U.S.A., Inc. Dr. Kiyoizumi earned his MD and PhD degrees
from the Keio University School of Medicine in Tokyo, where he was an
Assistant Professor of Plastic and Reconstructive Surgery. He holds a
Master of Science degree in Management (MBA) from the Sloan School of
Management at Massachusetts Institute of Technology. Profile
Dr. Kiyoizumi: MediciNova is a privately held specialty pharmaceutical
company based in San Diego and was founded in September 2000. We
